Italy· 050382035
EMYLIF*56 bust film orodispers 50 mg
A medicinal product containing riluzolo, registered in Italy by ZAMBON SpA, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Riluzolo
- Manufacturer
- ZAMBON SpA
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic050382035EMYLIF*56 bust film orodispers 50 mgEUR 197.87
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Riluzolo in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEmylif 50mg orodispersible filmsZambon UK Ltd
- CzechiaRILUTEKSanofi Winthrop Industrie, Gentilly
- United StatesriluzoleGlenmark Pharmaceuticals Inc., USA
- GermanyEmylifZambon S.P.A.
- FranceEMYLIF 50 mg, film orodispersibleZAMBON (ITALIE)
- NetherlandsEmylif 50 mg orodispergeerbare filmZambon S.p.A.
- BelgiumEmylif 50 mgZambon
- SwedenGlentek 50 mg Filmdragerad tablettGlenmark Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Emylif, Riluzol Aristo
- Belgium · Emylif, Riluzol Ab
- Cyprus · Teglutik
- Czechia · Riluzol Pmcs
- Germany · Emylif, Glentek
- Denmark · Emylif, Glentek
- Estonia · Lizolorol, Rilustad
- Spain · Emylif, Riluzol Aurovitas
- Finland · Teglutik
- France · Emylif, Riluzole Arrow
- United Kingdom (Northern Ireland) · Emylif, Riluzole Accord Healthcare
- Greece · Teglutik
- Croatia · Alsemol
- Hungary · Sclefic
- Iceland · Emylif, Rilutek
- Liechtenstein · Rilutek, Riluzole Zentiva
- Luxembourg · Emylif, Teglutik
- Netherlands · Emylif, Glentek
- Norway · Emylif, Rilutek
- Poland · Riluzol Pmcs, Riluzole Sun
- Portugal · Emylif, Riluzol Aurovitas
- Romania · Riluzol Pmcs
- Sweden · Emylif, Glentek
- Slovenia · Sclefic
- Slovakia · Riluzol Pmcs
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/538a16b5-2af4-4832-8e22-a8c8b0e5281a GET /v1/drugs/538a16b5-2af4-4832-8e22-a8c8b0e5281a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 197.87,
"source": "aifa",
"currency": "EUR",
"strength": "RILUZOLO 50MG 56 UNITA' USO ORALE",
"substance": "Riluzolo",
"equivalence_group": "G5C",
"transparency_flag": null
}See everything about riluzolo.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.